Cell Biology
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human IL33 isoform 1 partial (112-270) recombinant protein | Login | Human IL33 isoform 1 partial (112-270) recombinant protein | ||||||||||||||||
|
||||||||||||||||||
Human Interleukin-1 beta recombinant protein | Login | Human Interleukin-1 beta recombinant protein | ||||||||||||||||
|
||||||||||||||||||
Human Myoglobin recombinant protein | Login | Human Myoglobin recombinant protein | ||||||||||||||||
|
||||||||||||||||||
Human Programmed cell death protein 1 recombinant protein (PDCD1) | Login | Human Programmed cell death protein 1 recombinant protein (PDCD1) | ||||||||||||||||
|
||||||||||||||||||
Human Tumor necrosis factor receptor superfamily member 1A (TNFR1A) recombinant protein | Login | Human Tumor necrosis factor receptor superfamily member 1A (TNFR1A) recombinant protein | ||||||||||||||||
|
||||||||||||||||||
CD47 Protein - Mus musculus Leukocyte surface antigen CD47 recombinant protein | Login | CD47 Protein - Mus musculus Leukocyte surface antigen CD47 recombinant protein | ||||||||||||||||
|
||||||||||||||||||
Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade | Login | Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade | Login | Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | Login | Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | Login | Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade | Login | Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade | Login | Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | Login | Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | Login | Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | Login | Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | Login | Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
Vascular endothelial growth factor A(VEGFA) | Login | Vascular endothelial growth factor A(VEGFA) | ||||||||||||||||
|
||||||||||||||||||
Tubulinyl-Tyr carboxypeptidase 2 (VASH2) | Login | Tubulinyl-Tyr carboxypeptidase 2 (VASH2) | ||||||||||||||||
|
||||||||||||||||||
Interleukin-2(Il2) | Login | Interleukin-2(Il2) | ||||||||||||||||
|
||||||||||||||||||
Creatine kinase MB(CKMB) | Login | Creatine kinase MB(CKMB) | ||||||||||||||||
|
||||||||||||||||||
EGFR protein / Epidermal growth factor receptor(EGFR) | Login | EGFR protein / Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||
Fibrinogen-like protein 1(FGL1) | Login | Fibrinogen-like protein 1(FGL1) | ||||||||||||||||
|
||||||||||||||||||
Galectin-9(LGALS9) | Login | Galectin-9(LGALS9) | ||||||||||||||||
|